Peter Merrill

1.2k total citations · 1 hit paper
15 papers, 804 citations indexed

About

Peter Merrill is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Peter Merrill has authored 15 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Cardiology and Cardiovascular Medicine and 3 papers in Surgery. Recurrent topics in Peter Merrill's work include Diabetes Treatment and Management (7 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Diabetes Management and Research (3 papers). Peter Merrill is often cited by papers focused on Diabetes Treatment and Management (7 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Diabetes Management and Research (3 papers). Peter Merrill collaborates with scholars based in United States, United Kingdom and Italy. Peter Merrill's co-authors include Robert J. Mentz, Nayyar Iqbal, John B. Buse, Adrian F. Hernandez, Rury R. Holman, Yuliya Lokhnygina, Aldo P. Maggioni, Juliana C.N. Chan, Peter Öhman and Ambady Ramachandran and has published in prestigious journals such as Journal of the American College of Cardiology, Diabetes Care and Diabetes.

In The Last Decade

Peter Merrill

15 papers receiving 791 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis

2017 413 citations M. Angelyn Bethel, Rishi Patel et al. The Lancet Diabetes & Endocrinology profile →

Peers

Peter Merrill

EDM

CCM

SURGE

PHARM

Sarah Nethercott United Kingdom

Giulia Ferrannini Sweden

Mauro Tancredi Sweden

Valeria Frighi United Kingdom

K. Malmberg Sweden

L. K. Stevens United Kingdom

Melissa Magwire United States

Martin M.-T. Fuh Taiwan

Bernard MY Cheung Hong Kong

Jean-Philippe Kévorkian France

Sarah Nethercott United Kingdom

Peter Merrill

765 ×1.4

EDM

245 ×1.0

CCM

194 ×0.9

175 ×0.9

SURGE

64 ×0.6

PHARM

Citations per year, relative to Peter Merrill Peter Merrill (= 1×) peers Sarah Nethercott

Countries citing papers authored by Peter Merrill

Since Specialization

Citations

This map shows the geographic impact of Peter Merrill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Merrill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Merrill more than expected).

Fields of papers citing papers by Peter Merrill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Merrill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Merrill. The network helps show where Peter Merrill may publish in the future.

Co-authorship network of co-authors of Peter Merrill

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Merrill. A scholar is included among the top collaborators of Peter Merrill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Merrill. Peter Merrill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Green, Jennifer B., Peter Merrill, Yuliya Lokhnygina, et al.. (2023). Sex differences in the complications, care and clinical outcomes of patients with type 2 diabetes in the Exenatide Study of Cardiovascular Event Lowering ( EXSCEL ). Diabetes Obesity and Metabolism. 25(6). 1473–1484. 1 indexed citations

Carey, Erin T., Elizabeth J. Geller, Andrea J. Rapkin, et al.. (2022). Rationale and design of a multicenter randomized clinical trial of vestibulodynia: understanding pathophysiology and determining appropriate treatments (vestibulodynia: UPDATe). Annals of Medicine. 54(1). 2884–2896. 4 indexed citations

Armstrong, Sarah, Nathan A. Bihlmeyer, Jennifer S. Li, et al.. (2020). Rationale and design of “Hearts & Parks”: study protocol for a pragmatic randomized clinical trial of an integrated clinic-community intervention to treat pediatric obesity. BMC Pediatrics. 20(1). 308–308. 7 indexed citations

Bethel, M. Angelyn, Rishi Patel, Vivian P. Thompson, et al.. (2019). Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL). Diabetes Care. 42(6). 1075–1080. 26 indexed citations

Bethel, M. Angelyn, Robert J. Mentz, Peter Merrill, et al.. (2019). Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial. Diabetes Care. 43(2). 446–452. 78 indexed citations

Merrill, Peter, John B. Buse, Brian G. Katona, et al.. (2019). PATIENTS WITH DIABETES AND PERIPHERAL ARTERIAL DISEASE: RESULTS FROM THE EXSCEL TRIAL. Journal of the American College of Cardiology. 73(9). 2040–2040. 1 indexed citations

Merrill, Peter, John B. Buse, Shaun G. Goodman, et al.. (2019). Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease. Circulation Cardiovascular Interventions. 12(12). e008018–e008018. 26 indexed citations

Bethel, M. Angelyn, Robert J. Mentz, Peter Merrill, et al.. (2018). Renal Outcomes in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL). Diabetes. 67(Supplement_1). 46 indexed citations

Goto, Shinya, Peter Merrill, Lars Wallentin, et al.. (2018). Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE. European Heart Journal - Cardiovascular Pharmacotherapy. 4(2). 75–81. 2 indexed citations

10.

Mentz, Robert J., M. Angelyn Bethel, Peter Merrill, et al.. (2018). Effect of Once‐Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial. Journal of the American Heart Association. 7(19). e009304–e009304. 15 indexed citations

11.

Luo, Nancy, Peter Merrill, Kishan S. Parikh, et al.. (2017). Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation. Journal of the American College of Cardiology. 69(13). 1683–1691. 41 indexed citations

12.

Bethel, M. Angelyn, Rishi Patel, Peter Merrill, et al.. (2017). Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis. The Lancet Diabetes & Endocrinology. 6(2). 105–113. 413 indexed citations breakdown →

13.

Merrill, Peter, et al.. (2017). Representation of black patients in randomized clinical trials of heart failure with reduced ejection fraction. American Heart Journal. 197. 43–52. 18 indexed citations

14.

Luo, Nancy, Peter Merrill, David J. Whellan, et al.. (2016). Exercise Training in Patients with Chronic Heart Failure and Atrial Fibrillation: Results from the HF-ACTION Trial. Journal of Cardiac Failure. 22(8). S71–S71. 3 indexed citations

15.

Meschia, James F., Peter Merrill, Elsayed Z. Soliman, et al.. (2010). Racial Disparities in Awareness and Treatment of Atrial Fibrillation. Stroke. 41(4). 581–587. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact